doi:10.1056/NEJMoa2502081
improves with slower dose escalation Vomiting, diarrhea, or constipation Bloating, heartburn, or stomach discomfort Reduced appetite and early fullness Fatigue or headache Less common side effects Injection-site reactions Fatigue or changes in taste Temporary mild hair thinning (limited evidence) Serious but rare risks Pancreatitis seek care immediately if you experience severe abdominal pain Gallbladder disease or gallstones Kidney complications, particularly from dehydration Thyroid C-cell tumor risk in patients with medullary thyroid cancer history or MEN2 Low blood sugar when combined with insulin or sulfonylureas Contact your provider immediately if you experience severe or persistent abdominal pain, constant vomiting, signs of dehydration, yellowing of the skin or eyes, or symptoms of low blood sugar
Exenatide, metformin, or both for prediabetes in PCOS: A randomized, open-label, parallel-group controlled study
An update on the safety of SGLT2 inhibitors
Firstly, it is necessary to ensure the sterility of the syringe and needle to avoid infection
GHK-Cu (35mg) is the tripeptide glycyl-L-histidyl-L-lysine complexed with a copper(II) ion, first isolated from human blood plasma by Dr